Synthesis of ADP‐Ribose Mimetics as Potent Inhibitors for the Coronavirus Hydrolase Mac1
Chemistry – A European Journal · 13.11.2026
DOI: 10.1002/chem.71898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 13.11.2026. Verfasst von Koen J Rijpkema und 7 weiteren Autor:innen. Beteiligte Einrichtung: Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, CRUK.
Abstract (Originalsprache)
We describe the design and synthesis of α‐azido‐4‐thioribose and α‐epoxycarbaribose‐based adenosine diphosphate ribose (ADP‐ribose) analogs as potent inhibitors of the SARS‐CoV‐2 macrodomain Mac1. The α‐epoxycarbaribose was designed to emulate the structure of the distal ribose of ADPr, which adopts an E 3 conformation during hydrolysis and release from the target protein. In addition, a sulfonyl carbamate linker and the remdesivir‐inspired nucleobase GS‐441524 were incorporated into our designs to increase inhibitor lipophilicity and potency, respectively. The α‐epoxycarbaribose GS‐441524 pyrophosphate was identified as the most potent Mac1 inhibitor to date, exhibiting low‐nanomolar affinity. Replacing pyrophosphate with the less polar sulfonyl carbamate linker yielded an inhibitor with an IC50 of 19 nM. Analysis of co‐crystal structures of Mac1 and its inhibitors showed that the epoxide is intact and revealed that the sulfonyl carbamate linker positions itself to mimic pyrophosphate binding.
Autor:innen und Institutionen
- Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
ORCID-Profile: Koen J Rijpkema, Marion Schuller, Roy Steneker, Bas van den Berg, Jerom Sman, Jeroen D C Codée, Ivan Ahel, Dmitri V Filippov
Förderung
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- CRUK
- Oxford University Challenge Seed Fund
- Cancer Research UK
Zitieren
APA
Rijpkema, K. J., Schuller, M., Steneker, R., Berg, B. V. D., Sman, J., Codée, J. D. C., Ahel, I., & Filippov, D. V. (2026). Synthesis of ADP‐Ribose Mimetics as Potent Inhibitors for the Coronavirus Hydrolase Mac1. Chemistry – A European Journal. https://doi.org/10.1002/chem.71898
Vancouver
Rijpkema KJ, Schuller M, Steneker R, Berg BVD, Sman J, Codée JDC, et al. Synthesis of ADP‐Ribose Mimetics as Potent Inhibitors for the Coronavirus Hydrolase Mac1. Chemistry – A European Journal. 2026. doi:10.1002/chem.71898
BibTeX
@article{Rijpkema2026,
author = {Rijpkema, Koen J and Schuller, Marion and Steneker, Roy and Berg, Bas van den and Sman, Jerom and Codée, Jeroen D C and Ahel, Ivan and Filippov, Dmitri V},
title = {Synthesis of ADP‐Ribose Mimetics as Potent Inhibitors for the Coronavirus Hydrolase Mac1},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71898}
}
EUVIMED